ARTICLE | Company News
Evotec and Abivax partner to target infectious diseases
September 15, 2017 7:15 PM UTC
Evotec AG (Xetra:EVT) and Abivax S.A.S. (Euronext Paris:ABVX) partnered to discover and develop compounds to treat viral infectious including respiratory syncytial virus (RSV), influenza and dengue fever. Abivax will identify targets and use its antiviral platform to discover compounds. Evotec will optimize the candidates. Abivax retains all rights to IP. ...